vs
Side-by-side financial comparison of AbCellera Biologics Inc. (ABCL) and HEALTHSTREAM INC (HSTM). Click either name above to swap in a different company.
HEALTHSTREAM INC is the larger business by last-quarter revenue ($79.7M vs $44.9M, roughly 1.8× AbCellera Biologics Inc.). On growth, AbCellera Biologics Inc. posted the faster year-over-year revenue change (788.4% vs 7.4%). HEALTHSTREAM INC produced more free cash flow last quarter ($13.0M vs $-44.6M). Over the past eight quarters, AbCellera Biologics Inc.'s revenue compounded faster (112.3% CAGR vs 4.7%).
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.
HealthStream Inc is a leading U.S.-based provider of workforce development, compliance, and training solutions tailored for the healthcare industry. It offers cloud-based platforms covering clinical skill training, talent management, patient safety education, and regulatory adherence tools, serving over 4,000 healthcare organizations including hospitals, clinics, and long-term care facilities nationwide.
ABCL vs HSTM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $44.9M | $79.7M |
| Net Profit | $-8.9M | — |
| Gross Margin | — | — |
| Operating Margin | -63.7% | 3.0% |
| Net Margin | -19.9% | — |
| Revenue YoY | 788.4% | 7.4% |
| Net Profit YoY | 73.9% | — |
| EPS (diluted) | $-0.03 | $0.09 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $44.9M | $79.7M | ||
| Q3 25 | $9.0M | $76.5M | ||
| Q2 25 | $17.1M | $74.4M | ||
| Q1 25 | $4.2M | $73.5M | ||
| Q4 24 | $5.0M | $74.2M | ||
| Q3 24 | $6.5M | $73.1M | ||
| Q2 24 | $7.3M | $71.6M | ||
| Q1 24 | $10.0M | $72.8M |
| Q4 25 | $-8.9M | — | ||
| Q3 25 | $-57.1M | $6.1M | ||
| Q2 25 | $-34.7M | $5.4M | ||
| Q1 25 | $-45.6M | $4.3M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-51.1M | $5.7M | ||
| Q2 24 | $-36.9M | $4.2M | ||
| Q1 24 | $-40.6M | $5.2M |
| Q4 25 | -63.7% | 3.0% | ||
| Q3 25 | -851.8% | 9.9% | ||
| Q2 25 | -290.2% | 7.9% | ||
| Q1 25 | -1479.6% | 6.0% | ||
| Q4 24 | — | 6.3% | ||
| Q3 24 | -1439.4% | 8.9% | ||
| Q2 24 | -1276.2% | 6.2% | ||
| Q1 24 | -551.5% | 7.8% |
| Q4 25 | -19.9% | — | ||
| Q3 25 | -637.8% | 8.0% | ||
| Q2 25 | -203.3% | 7.2% | ||
| Q1 25 | -1077.2% | 5.9% | ||
| Q4 24 | — | — | ||
| Q3 24 | -785.4% | 7.8% | ||
| Q2 24 | -504.3% | 5.8% | ||
| Q1 24 | -408.0% | 7.2% |
| Q4 25 | $-0.03 | $0.09 | ||
| Q3 25 | $-0.19 | $0.20 | ||
| Q2 25 | $-0.12 | $0.18 | ||
| Q1 25 | $-0.15 | $0.14 | ||
| Q4 24 | — | $0.16 | ||
| Q3 24 | $-0.17 | $0.19 | ||
| Q2 24 | $-0.13 | $0.14 | ||
| Q1 24 | $-0.14 | $0.17 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $128.5M | $36.2M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $966.9M | $354.0M |
| Total Assets | $1.4B | $520.4M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $128.5M | $36.2M | ||
| Q3 25 | $83.2M | $53.5M | ||
| Q2 25 | $92.4M | $52.1M | ||
| Q1 25 | $159.3M | $77.3M | ||
| Q4 24 | $156.3M | $59.5M | ||
| Q3 24 | $126.6M | $57.5M | ||
| Q2 24 | $148.3M | $46.1M | ||
| Q1 24 | $123.6M | $52.4M |
| Q4 25 | $966.9M | $354.0M | ||
| Q3 25 | $964.0M | $349.2M | ||
| Q2 25 | $1.0B | $350.6M | ||
| Q1 25 | $1.0B | $362.8M | ||
| Q4 24 | $1.1B | $359.4M | ||
| Q3 24 | $1.1B | $355.5M | ||
| Q2 24 | $1.1B | $349.2M | ||
| Q1 24 | $1.1B | $344.9M |
| Q4 25 | $1.4B | $520.4M | ||
| Q3 25 | $1.4B | $499.9M | ||
| Q2 25 | $1.4B | $500.1M | ||
| Q1 25 | $1.3B | $524.0M | ||
| Q4 24 | $1.4B | $510.8M | ||
| Q3 24 | $1.4B | $502.8M | ||
| Q2 24 | $1.4B | $499.6M | ||
| Q1 24 | $1.5B | $511.6M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-34.7M | $13.2M |
| Free Cash FlowOCF − Capex | $-44.6M | $13.0M |
| FCF MarginFCF / Revenue | -99.4% | 16.3% |
| Capex IntensityCapex / Revenue | 21.9% | 0.3% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-174.1M | $59.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-34.7M | $13.2M | ||
| Q3 25 | $-52.6M | $18.0M | ||
| Q2 25 | $-32.4M | $5.0M | ||
| Q1 25 | $-11.6M | $27.1M | ||
| Q4 24 | $-108.6M | $11.2M | ||
| Q3 24 | $-28.9M | $19.1M | ||
| Q2 24 | $-30.0M | $6.5M | ||
| Q1 24 | $-41.7M | $20.9M |
| Q4 25 | $-44.6M | $13.0M | ||
| Q3 25 | $-61.5M | $17.9M | ||
| Q2 25 | $-45.8M | $2.7M | ||
| Q1 25 | $-22.2M | $26.0M | ||
| Q4 24 | $-187.0M | $11.0M | ||
| Q3 24 | $-47.4M | $18.8M | ||
| Q2 24 | $-50.1M | $6.3M | ||
| Q1 24 | $-65.8M | $20.2M |
| Q4 25 | -99.4% | 16.3% | ||
| Q3 25 | -687.0% | 23.4% | ||
| Q2 25 | -267.9% | 3.6% | ||
| Q1 25 | -524.0% | 35.4% | ||
| Q4 24 | -3702.8% | 14.8% | ||
| Q3 24 | -728.4% | 25.8% | ||
| Q2 24 | -683.8% | 8.8% | ||
| Q1 24 | -661.5% | 27.8% |
| Q4 25 | 21.9% | 0.3% | ||
| Q3 25 | 99.7% | 0.1% | ||
| Q2 25 | 78.2% | 3.1% | ||
| Q1 25 | 251.1% | 1.4% | ||
| Q4 24 | 1552.7% | 0.3% | ||
| Q3 24 | 284.6% | 0.4% | ||
| Q2 24 | 274.6% | 0.2% | ||
| Q1 24 | 242.5% | 1.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | 2.96× | ||
| Q2 25 | — | 0.93× | ||
| Q1 25 | — | 6.25× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 3.34× | ||
| Q2 24 | — | 1.55× | ||
| Q1 24 | — | 4.01× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ABCL
Segment breakdown not available.
HSTM
| Subscription Services | $77.0M | 97% |
| Professional Services | $2.7M | 3% |
